2023 Duke-国际心血管感染性疾病学会感染性心内膜炎诊断标准与改良Duke标准及临床管理的关系:回顾性菌血症队列再分析
该研究再分析4050例菌血症发作,比较2023 Duke-ISCVID标准与2000改良Duke标准对感染性心内膜炎(IE)的分类及与治疗的关系。Duke-ISCVID将13例(0.3%)从可能IE重分类为确定IE,475例(12%)从排除IE重分类为可能IE;以治疗IE为参考标准,Duke-ISCVID敏感性为80%,重分类为可能IE的475例均未按IE治疗。
要点
- Duke-ISCVID标准将0.3%发作从可能IE重分类为确定IE,12%从排除IE重分类为可能IE。
- 以治疗IE为参考标准,Duke-ISCVID标准的敏感性为80%。
- 重分类为可能IE的475例发作均未按IE治疗。
核心结论
- Duke-ISCVID标准将小部分发作重分类为确定IE,但代价是更多发作被归为可能IE。
- 未来标准应尽量减少可能IE组,同时保持或提高敏感性。
研究设计与样本
- 再分析金黄色葡萄球菌、圣路易斯葡萄球菌、非β溶血性链球菌、类链球菌细菌、停乳链球菌、粪肠球菌和HACEK(嗜血杆菌、聚集杆菌、心杆菌、艾肯菌、金杆菌)菌血症患者队列。
- 共4050例菌血症发作,分别用改良Duke标准和Duke-ISCVID标准分类为确定、可能或排除IE。
- 重分类包括微生物学标准、正电子发射断层扫描-计算机断层扫描和心脏植入电子装置。
- 以接受IE治疗的患者视为患有IE来计算敏感性。
主要发现
- 改良Duke标准将307例发作(7.6%)归为确定IE,1190例(29%)为可能IE,2553例(63%)为排除IE。
- Duke-ISCVID标准将13例发作(0.3%)从可能IE重分类为确定IE,475例发作(12%)从排除IE重分类为可能IE。
- 改良Duke标准下79例按IE治疗的发作被归为可能IE,其中11例经Duke-ISCVID重分类为确定IE。
- 以治疗IE决策为参考标准,Duke-ISCVID标准的敏感性为80%。
- 重分类为可能IE的475例发作均未按IE治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revised diagnostic criteria for infective endocarditis (IE), the 2023 Duke-ISCVID criteria, were recently presented and need validation. Here, we compare the 2000 modified Duke criteria for IE with Duke-ISCVID among patients with bacteremia and relate the diagnostic classification to IE treatment. METHODS: We reanalyzed patient cohorts with Staphylococcus aureus, Staphylococcus lugdunensis, non-β-hemolytic streptococci, Streptococcus-like bacteria, Streptococcus dysgalactiae, Enterococcus faecalis, and HACEK (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella) bacteremia. Episodes were classified as definite, possible, or rejected IE with the modified Duke and Duke-ISCVID criteria. Reclassification included the microbiology criteria, positron emission tomography-computed tomography, and cardiac implanted electronic devices. To calculate sensitivity, patients treated for IE were considered as having IE. RESULTS: In 4050 episodes of bacteremia, the modified Duke criteria assigned 307 episodes (7.6%) as definite IE, 1190 (29%) as possible IE, and 2553 (63%) as rejected IE. Using the Duke-ISCVID criteria, 13 episodes (0.3%) were reclassified from possible to definite IE, and 475 episodes (12%) were reclassified from rejected to possible IE. With the modified Duke criteria, 79 episodes that were treated as IE were classified as possible IE, and 11 of these episodes were reclassified to definite IE with Duke-ISCVID. Applying the decision to treat for IE as a reference standard, the sensitivity of the Duke-ISCVID criteria was 80%. None of the 475 episodes reclassified to possible IE were treated as IE. CONCLUSIONS: The Duke-ISCVID criteria reclassified a small proportion of episodes to definite IE at the expense of more episodes of possible IE. Future criteria should minimize the possible IE group while keeping or improving sensitivity.
引用
- Lindberg H, Berge A, Jovanovic-Stjernqvist M, et al. Performance of the 2023 Duke-International Society of Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis in Relation to the Modified Duke Criteria and to Clinical Management-Reanalysis of Retrospective Bacteremia Cohorts. Clin Infect Dis. 2024. PMID: 38330240. doi:10.1093/cid/ciae040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。